Oral cholesteryl ester transfer protein (CETP) inhibitors: A potential new approach for treating coronary artery disease

被引：114
作者：
Sikorski, JA [1 ]
机构：
[1] AtheroGen Inc, Discovery Med Chem, Alpharetta, GA 30004 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2006年 / 49卷 / 01期
关键词：
D O I：
10.1021/jm058224l
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 22
页数：22
相关论文
共 210 条
[1]  
AGELLON LB, 1991, J BIOL CHEM, V266, P10796
[2]  
Agerholm-Larsen B, 2000, CIRCULATION, V102, P2197
[3]   JTT-705 -: Treatment of lipoprotein disorders cholesteryl ester transfer protein inhibitor [J].
Alegret, M ;
Silvestre, JS ;
Castañer, J .
DRUGS OF THE FUTURE, 2004, 29 (08) :787-792
[4]  
ALLEN DJM, 2001, Patent No. 2001040190
[5]  
[Anonymous], MOL MECH ATHEROSCLER
[6]   Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment [J].
Ansell, BJ ;
Navab, M ;
Hama, S ;
Kamranpour, N ;
Fonarow, G ;
Hough, G ;
Rahmani, S ;
Mottahedeh, R ;
Dave, R ;
Reddy, ST ;
Fogelman, AM .
CIRCULATION, 2003, 108 (22) :2751-2756
[7]   Deficiency of choresteryl ester transfer protein and gene polymorphisms of lipoprotein lipase and hepatic lipase are not associated with longevity [J].
Arai, Y ;
Hirose, N ;
Yamamura, K ;
Nakazawa, S ;
Shimizu, K ;
Takayama, M ;
Ebihara, Y ;
Homma, S ;
Gondo, Y ;
Masui, Y ;
Inagaki, H .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (02) :102-109
[8]  
Arai Yasumichi, 2004, J Atheroscler Thromb, V11, P246
[9]   Increased serum cholesteryl ester transfer protein in obese children [J].
Asayama, K ;
Hayashibe, H ;
Dobashi, K ;
Uchida, N ;
Nakane, T ;
Kodera, K ;
Shirahata, A .
OBESITY RESEARCH, 2002, 10 (06) :439-446
[10]   Atheroprotective effects of high-density lipoproteins [J].
Assmann, G ;
Nofer, JR .
ANNUAL REVIEW OF MEDICINE, 2003, 54 :321-341
12345678910